المؤلفون: Turner, Nicholas C, Balmaña, Judith, Poncet, Coralie, Goulioti, Theodora, Tryfonidis, Konstantinos, Honkoop, Aafke H, Zoppoli, Gabriele, Razis, Evangelia, Johannsson, Oskar T, Colleoni, Marco, Tutt, Andrew N, Audeh, William, Ignatiadis, Michail, Mailliez, Audrey, Trédan, Olivier, Musolino, Antonino, Vuylsteke, Peter, Juan-Fita, Maria Jose, Macpherson, Iain R J, Kaufman, Bella, Manso, Luis, Goldstein, Lori J, Ellard, Susan L, Láng, István, Jen, Kai Yu, Adam, Virginie, Litière, Saskia, Erban, John, Cameron, David A

المساهمون: 1Institute of Cancer Research and Royal Marsden, London, United Kingdom. 2Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology, Barcelona, Spain. 3European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium. 4Breast International Group, Brussels, Belgium. 5Borstkanker Onderzoeksgroep Nederland (BOOG), Amsterdam, the Netherlands. 6Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC), Parma, Italy, and Ospedale Policlinico IRCCS San Martino and Università degli Studi di Genova, Genova, Italy. 7Hygeia Hospital, Marousi, Athens, Greece. 8Department of Clinical Oncology, Landspitali The National University Hospital of Iceland, Reykjavik, Iceland. 9Division of Medical Senology, IEO, European Institute of Oncology, IRCCS, Milan, Italy. 10Guy's and St Thomas's NHS Foundation Trust and The Breast Cancer Now Toby Robins Breast Cancer Research Center, The Institute of Cancer Research, London, United Kingdom. 11Cedars-Sinai Cancer Center, Los Angeles, California. 12Agendia, Inc., Irvine, California. 13Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. 14Center Oscar Lambret, Lille, France. 15Center Léon Bérard, Lyon, France. 16Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC), Parma, Italy, and Medical Oncology and Breast Unit, University Hospital of Parma, Department of Medicine and Surgery, University of Parma, Parma, Italy. 17UCLouvain, CHU Namur, Belgium and University of Botswana, Gaborone, Botswana. 18Instituto Valenciano de Oncología, Valencia, Spain, and GEICAM Spanish Breast Cancer Group. 19Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom. 20Sheba Medical Center, Ramat Gan, Israel. 21Hospital Universitario 12 de Octubre, Madrid, Comunidad de Madrid, Spain. 22Fox Chase Cancer Center, Philadelphia, Pennsylvania. 23BC Cancer, Kelowna, British Columbia, Canada. 24Istenhegyi Gèndiagnosztika Private Health Center Oncology Unit, Budapest, Hungary. 25GlaxoSmithKline/Tesaro, Waltham, Massachusetts. 26Tufts University School of Medicine, Boston, Massachusetts.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research ; 27 ; 20 ; 5482 ; 5491 ; United States

مصطلحات موضوعية: Brjóstakrabbamein, Breast Neoplasms, BRCA1 Protein, BRCA2 Protein, BCG Vaccine, Nitriles

العلاقة: https://clincancerres.aacrjournals.org/content/27/20/5482.full-text.pdfTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530899Test/; Turner NC, Balmaña J, Poncet C, et al. Niraparib for Advanced Breast Cancer with Germline BRCA1 and BRCA2 Mutations: the EORTC 1307-BCG/BIG5-13/TESARO PR-30-50-10-C BRAVO Study. Clin Cancer Res. 2021;27(20):5482-5491. doi:10.1158/1078-0432.CCR-21-0310; http://hdl.handle.net/2336/622028Test; Clinical cancer research : an official journal of the American Association for Cancer Research

الإتاحة: https://doi.org/10.1158/1078-0432.CCR-21-0310Test
http://hdl.handle.net/2336/622028Test

المؤلفون: Climent, Miguel A., Font, Albert, Durán, Ignacio, Puente, Javier, José Méndez-Vidal, María, Sáez, María Isabel, Santander Lobera, Carmen, Ángel Arranz Arija, Jóse, González-del-Alba, Aranzazu, Sánchez-Hernandez, Alfredo, Juan Fita, Maria Jose, Esteban, Emilio, Alonso-Gordoa, Teresa, Mellado Gonzalez, Begoña, Maroto, Pablo, Lázaro-Quintela, Martín, Cassinello-Espinosa, Javier, Pérez-Valderrama, Begoña, Garcias, Carmen, Castellano, Daniel

المصدر: European Journal of Cancer ; volume 175, page 110-119 ; ISSN 0959-8049

مصطلحات موضوعية: Cancer Research, Oncology

الإتاحة: https://doi.org/10.1016/j.ejca.2022.08.002Test
https://api.elsevier.com/content/article/PII:S0959804922004671?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0959804922004671?httpAccept=text/plainTest

المؤلفون: Juan Fita, María José

مرشدي الرسالة: Lluch Hernández, Ana, López Guerrero, José Antonio, Ruiz Simón, Amparo, Departament de Medicina

مصطلحات موضوعية: cáncer de mama, cirugia conservadora, mutación BRCA 1/2, recaida locorregional

الوصول الحر: http://hdl.handle.net/10550/50586Test

المؤلفون: Juan Fita, María José

مرشدي الرسالة: Lluch Hernández, Ana, López Guerrero, José Antonio, Ruiz Simón, Amparo, Departament de Medicina

مصطلحات موضوعية: cáncer de mama, cirugia conservadora, mutación BRCA 1/2, recaida locorregional

الوصول الحر: http://hdl.handle.net/10803/570576Test

المؤلفون: Juan Fita, María José

مرشدي الرسالة: Lluch Hernández, Ana, López Guerrero, José Antonio, Ruiz Simón, Amparo, Departament de Medicina

مصطلحات موضوعية: cáncer de mama, cirugia conservadora, mutación BRCA 1/2, recaida locorregional

الوصول الحر: http://hdl.handle.net/10550/50586Test

المؤلفون: Juan Fita, María José¹ (AUTHOR) macliment@fivo.org, Anido Herranz, Urbano² (AUTHOR) urbano.anido.herranz@sergas.es, Mendez-Vidal, María José³ (AUTHOR) mjosemv@yahoo.es, Gironés-Sarrió, Regina⁴ (AUTHOR) girones_reg@gva.es, Muñoz-Langa, José⁵ (AUTHOR) munyoz_joslan@gva.es, Sepúlveda-Sánchez, Juan⁶ (AUTHOR) sepulvedasanchez@seom.org, Mellado, Begoña^7,8 (AUTHOR) bmellado@clinic.cat, Alvarez-Fernandez, Carlos⁹ (AUTHOR) carlos.alvfer@gmail.com, Heras López, Lucía¹⁰ (AUTHOR) lheras@iconcologia.net, López-Guerrero, José Antonio^11,12 (AUTHOR) ja.lopez@ucv.es, García-Casado, Zaida¹¹ (AUTHOR) zgarcia@fivo.org, Calatrava, Ana¹³ (AUTHOR) acalatrava@fivo.org, Ángel Climent, Miguel¹ (AUTHOR)

المصدر: Cancers. Nov2023, Vol. 15 Issue 21, p5223. 12p.

مصطلحات موضوعية: *RESEARCH, *COMBINATION drug therapy, *CLINICAL trials, *CONFIDENCE intervals, *HOMOGRAFTS, *METASTASIS, *CASTRATION-resistant prostate cancer, *TREATMENT effectiveness, *DOCETAXEL, *DESCRIPTIVE statistics, *CELLS, *RESEARCH funding, *PROGRESSION-free survival, *ENZYME inhibitors

مصطلحات جغرافية: SPAIN

المؤلفون: Turner, Nicholas C, Balmaña, Judith, Poncet, Coralie, Goulioti, Theodora, Tryfonidis, Konstantinos, Honkoop, Aafke A.H., Zoppoli, Gabriele, Razis, Evangelia, Johannsson, Oskar Th, Colleoni, Marco Angelo, Tutt, Andrew M, Audeh, William, Ignatiadis, Michail, Mailliez, Audrey, Tredan, Olivier, Musolino, Antonino, Vuylsteke, Peter, Juan-Fita, Maria Jose, Macpherson, Iain R J, Kaufman, Bella, Manso, Luis, Goldstein, Lori L.J., Ellard, Susan S.L., Láng, István, Jen, Kai Yu, Adam, Virginie, Litière, Saskia, Erban, John, Cameron, David A

المصدر: Clinical cancer research, 27 (20

مصطلحات موضوعية: Cancérologie

وصف الملف: 1 full-text file(s): application/pdf

العلاقة: uri/info:doi/10.1158/1078-0432.CCR-21-0310; uri/info:pmid/34301749; uri/info:scp/85117416618; https://dipot.ulb.ac.be/dspace/bitstream/2013/333689/1/doi_317333.pdfTest; http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/333689Test

الإتاحة: http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/333689Test

المؤلفون: Turner, Nicholas C., Balmaña, Judith, Poncet, Coralie, Goulioti, Theodora, Tryfonidis, Konstantinos, Honkoop, Aafke H., Zoppoli, Gabriele, Razis, Evangelia, Johannsson, Oskar Th, Colleoni, Marco, Tutt, Andrew N. J., AUDEH, William, Ignatiadis, Michail, Mailliez, Audrey, Trédan, Olivier, Musolino, Antonino, Vuylsteke, Peter, Juan Fita, Maria Jose, Macpherson, Iain R.J., Kaufman, Bella, Manso, Luis, Goldstein, Lori J., Ellard, Susan L, Láng, István, Jen, Kai Yu, Adam, Virginie, Litière, Saskia, Erban, John, Cameron, David A

وصف الملف: text

العلاقة: http://eprints.gla.ac.uk/247220/1/247220.pdfTest; Turner, N. C. et al. (2021) Niraparib for advanced breast cancer with germline BRCA1 and BRCA2 mutations: the EORTC 1307-BCG/BIG5-13/TESARO PR-30-50-10-C BRAVO study. Clinical Cancer Research , 27(20), pp. 5482-5491. (doi:10.1158/1078-0432.CCR-21-0310 ) (PMID:34301749) (PMCID:PMC8530899)

الإتاحة: https://doi.org/10.1158/1078-0432.CCR-21-0310Test
http://eprints.gla.ac.uk/247220Test/
http://eprints.gla.ac.uk/247220/1/247220.pdfTest

المؤلفون: Lozano, Rebeca, Castro, Elena, Lopez-Campos, Fernando, Thorne, Heather, Ramirez-Backhaus, Miguel, Aragon, Isabel M., Cendón-Florez, Ylenia, Gutierrez-Pecharroman, Ana, Salles, Daniela C., Romero-Laorden, Nuria, Lorente, David, González-Peramato, Pilar, Calatrava, Ana, Alonso, Concepción, Anido, Urbano, Arévalo-Lobera, Sara, Balmaña, Judith, Chirivella, Isabel, Juan-Fita, María José, Llort, Gemma, y Cajal, Teresa Ramón, Almagro, Elena, Alameda, Daniel, López-Casas, Pedro P., Herrera, Bernardo, Mateo, Joaquin, Pritchard, Colin C., Antonarakis, Emmanuel S., Lotan, Tamara L., Rubio-Briones, José, Sandhu, Shahneen, Olmos, David

المساهمون: Instituto de Salud Carlos III, Sociedad Española de Oncología Médica, CRIS Cancer Foundation

المصدر: European Journal of Cancer ; volume 185, page 105-118 ; ISSN 0959-8049

مصطلحات موضوعية: Cancer Research, Oncology

الإتاحة: https://doi.org/10.1016/j.ejca.2023.02.022Test
https://api.elsevier.com/content/article/PII:S0959804923001168?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0959804923001168?httpAccept=text/plainTest

المؤلفون: Puente, Javier, Lainez, Nuria, Dueñas, Marta, Méndez-Vidal, María José, Esteban, Emilio, Castellano, Daniel, Martínez-Fernández, Mónica, Basterretxea, Laura, Juan-Fita, María José, Antón-Aparicio, Luis M., León, Luis, Lambea, Julio, Pérez-Valderrama, Begoña, Vázquez, Sergio, Suárez, Cristina, García del Muro, Xavier, Gallardo, Enrique, Maroto, José Pablo, Samaniego, M. Luz, Suárez-Paniagua, Beatriz, Sanz, Julián, Paramio, Jesús M.

مصطلحات موضوعية: Biomarker, Long-term responders, Metastatic renal cell carcinoma, Primary refractory, Sunitinib

العلاقة: https://doi.org/10.18632/oncotarget.16494Test; Puente J, Laínez N, Dueñas M, Méndez-Vidal MJ, Esteban E, Castellano D, et al. Novel potential predictive markers of sunitinib outcomes in long-term responders versus primary refractory patients with metastatic clear-cell renal cell carcinoma. Oncotarget. 2017;8(18):30410-30421; http://hdl.handle.net/2183/21038Test

الإتاحة: https://doi.org/10.18632/oncotarget.16494Test
http://hdl.handle.net/2183/21038Test